Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.4508
+0.0007 (0.16%)
At close: Jul 16, 2025, 4:00 PM
0.4499
-0.0009 (-0.20%)
After-hours: Jul 16, 2025, 5:05 PM EDT
Cosmos Health Employees
Cosmos Health had 149 employees as of December 31, 2024. The number of employees increased by 26 or 21.14% compared to the previous year.
Employees
149
Change (1Y)
26
Growth (1Y)
21.14%
Revenue / Employee
$359,426
Profits / Employee
-$143,151
Market Cap
12.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COSM News
- 22 days ago - Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech - GlobeNewsWire
- 2 months ago - RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - GlobeNewsWire
- 2 months ago - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven - GlobeNewsWire
- 2 months ago - Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units - GlobeNewsWire
- 2 months ago - Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq - GlobeNewsWire
- 2 months ago - Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 - GlobeNewsWire
- 3 months ago - Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million - GlobeNewsWire
- 3 months ago - Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L - GlobeNewsWire